Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Huber

Showing results (131-140 of 216) with videos related to

Pageof 22
Sort By:
Translational Stroke Research|October 10, 2021
Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent MannerOle Heinisch, Thomas Zeyen, Tobias Goldmann, et al.
European Journal of Immunology|March 1, 2006
R-form LPS, the master key to the activation ofTLR4/MD-2-positive cellsMichael Huber, Christoph Kalis, Simone Keck, et al.
Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.
Applied Microbiology and Biotechnology|February 26, 2022
Comparison of analytical sensitivity and efficiency for SARS-CoV-2 primer sets by TaqMan-based and SYBR Green-based RT-qPCRYile Tao, Yang Yue, Guangyu Qiu, et al.
Journal of Virology|December 11, 2012
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategiesKatie J Doores, Michael Huber, Khoa M Le, et al.
Blood|July 3, 2010
I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and developmentZane Orinska, Niko Föger, Michael Huber, et al.
Neuro-Degenerative Diseases|August 16, 2006
Active immunization of mice with an Abeta-Hsp70 vaccineMichael F Koller, M Hasan Mohajeri, Michael Huber, et al.
Cell Death & Disease|April 2, 2019
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitorsMohamed Mahameed, Thomas Wilhelm, Odai Darawshi, et al.
Swiss Medical Weekly|April 8, 2024
Exploring viral aetiology in upper respiratory tract infections: insights from metagenomic next-generation sequencing in Swiss outpatients before and during the SARS-CoV-2 pandemicVerena Kufner, Andrea C Frey, Sara H Burkhard, et al.
Acta Neuropathologica Communications|November 11, 2025
Anle138b mitigates post-hypoxic cognitive impairment, α-Synuclein aggregation and UPR activation in Drosophila melanogasterAaron T Fehr, Jennifer Jung, Alma Kokott-Vuong, et al.
Pageof 22

Showing results (131-140 of 216) with videos related to

Sort By:
Pageof 22
Translational Stroke Research|October 10, 2021
Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent MannerOle Heinisch, Thomas Zeyen, Tobias Goldmann, et al.
European Journal of Immunology|March 1, 2006
R-form LPS, the master key to the activation ofTLR4/MD-2-positive cellsMichael Huber, Christoph Kalis, Simone Keck, et al.
Plos Biology|March 24, 2021
SARS-CoV-2 variants reveal features critical for replication in primary human cellsMarie O Pohl, Idoia Busnadiego, Verena Kufner, et al.
Applied Microbiology and Biotechnology|February 26, 2022
Comparison of analytical sensitivity and efficiency for SARS-CoV-2 primer sets by TaqMan-based and SYBR Green-based RT-qPCRYile Tao, Yang Yue, Guangyu Qiu, et al.
Journal of Virology|December 11, 2012
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategiesKatie J Doores, Michael Huber, Khoa M Le, et al.
Blood|July 3, 2010
I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and developmentZane Orinska, Niko Föger, Michael Huber, et al.
Neuro-Degenerative Diseases|August 16, 2006
Active immunization of mice with an Abeta-Hsp70 vaccineMichael F Koller, M Hasan Mohajeri, Michael Huber, et al.
Cell Death & Disease|April 2, 2019
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitorsMohamed Mahameed, Thomas Wilhelm, Odai Darawshi, et al.
Swiss Medical Weekly|April 8, 2024
Exploring viral aetiology in upper respiratory tract infections: insights from metagenomic next-generation sequencing in Swiss outpatients before and during the SARS-CoV-2 pandemicVerena Kufner, Andrea C Frey, Sara H Burkhard, et al.
Acta Neuropathologica Communications|November 11, 2025
Anle138b mitigates post-hypoxic cognitive impairment, α-Synuclein aggregation and UPR activation in Drosophila melanogasterAaron T Fehr, Jennifer Jung, Alma Kokott-Vuong, et al.
Pageof 22